Antonio C. O.
- Country
- Spain
- Department
- Ophthalmology
Research Overview
- Evaluation of Timbetasin Acetate Ophthalmic Solution 0.1% for Neurotrophic Keratopathy: A Phase 3 Randomized, Double-Masked, Placebo-Controlled Study
- A Phase 3, Multicenter, Randomized, Double-Masked, Vehicle-Controlled, Study to Demonstrate Efficacy and Safety of DFL24498 Eye Drop Solution in Adult Participants with Atopic Keratoconjunctivitis (AKC)
- SEER-3: A Phase 3, Multi-Center, Randomized, Parallel, Double Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of Neurotrophic Keratopathy
Data & Insights
Has run more than one trial at 8 of 32 partner sites.
Specializations
Ophthalmology Focus
This investigator specializes in the study and treatment of neurotrophic keratopathy, a rare degenerative corneal condition affecting ocular surface integrity and corneal healing.
- Corneal Disease Management
- Ocular Surface Disorders
- Regenerative Ophthalmology
The investigator's work centers on evaluating novel therapeutic approaches for corneal conditions.
Therapeutic Expertise
Focused on advancing treatments in ophthalmic medicine, particularly through the investigation of innovative topical solutions for corneal disorders.
- Ophthalmic Solutions
- Clinical Efficacy Assessment
- Therapeutic Safety Evaluation
The investigator explores new therapeutic options for patients with degenerative corneal conditions.
Clinical Research
Conducts advanced research in corneal therapeutics, with particular emphasis on treatments for rare ophthalmic conditions.
- Treatment Development
- Ocular Surface Innovation
- Clinical Trial Design
The investigator contributes to the development of new therapeutic approaches in ophthalmology.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.